Form 25-NSE Apellis Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Red Rock Resorts Announces Date of Second Quarter 2026 Conference Call and Earnings Release Date
- Univest Securities, LLC Announces Closing of $750,000 Registered Direct Offering for its Client EShallGo Inc. (NASDAQ: EHGO)
- Donor Network West and Team CalNev secure Team Champion Award at Transplant Games of America
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
